Publication & Citation Trends
Publications
0 total
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.
Cited by 0
Semantic Scholar
Improving long-term outcomes in resectable pancreatic cancer
Cited by 0
Semantic Scholar
Extrachromosomal DNAs (ecDNAs) are associated with resistance to targeted therapies in pancreatic cancer
Cited by 0
Semantic Scholar
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer
Cited by 0
Semantic Scholar
CDKN2A and other 9p21 gene losses in pancreatic cancer are associated with impaired nucleic acid-sensing
Cited by 0
Semantic Scholar
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer.
Cited by 1
Semantic Scholar
Microbiome composition and its predictive value for chemotherapy response in pancreatic cancer: A multicenter study
Cited by 0
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(111)
Cancer Genomics and Diagnostics
(60)
Cholangiocarcinoma and Gallbladder Cancer Studies
(54)
Virus-based gene therapy research
(40)
Cancer Immunotherapy and Biomarkers
(30)
Affiliations
Champalimaud Foundation
Apple (Israel)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center